Accéder au contenu
Merck
Toutes les photos(2)

Documents

HT110232

Sigma-Aldrich

Eosin Y Solution, Aqueous

Se connecterpour consulter vos tarifs contractuels et ceux de votre entreprise/organisme
Toutes les photos(2)

About This Item

Code UNSPSC :
41116124
Nomenclature NACRES :
NA.47

Forme

solution

Durée de conservation

Expiry date on the label.

IVD

for in vitro diagnostic use

Concentration

0.5 % (w/v) in water

Application(s)

hematology
histology

Température de stockage

room temp

Vous recherchez des produits similaires ? Visite Guide de comparaison des produits

Application

General purpose cytoplasmic counterstain. Used with hematoxylin and eosin staining.

Autres remarques

Certified Eosin Y, 0.5% (w/v) in water. Not acidified.

Code de la classe de stockage

10 - Combustible liquids

Classe de danger pour l'eau (WGK)

WGK 2

Point d'éclair (°F)

Not applicable

Point d'éclair (°C)

Not applicable

Équipement de protection individuelle

Eyeshields, Gloves, multi-purpose combination respirator cartridge (US)

Certificats d'analyse (COA)

Recherchez un Certificats d'analyse (COA) en saisissant le numéro de lot du produit. Les numéros de lot figurent sur l'étiquette du produit après les mots "Lot" ou "Batch".

Déjà en possession de ce produit ?

Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.

Consulter la Bibliothèque de documents

Oliver Hachmöller et al.
Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS), 44, 71-75 (2017-10-03)
The influence of rhodanine and haematoxylin and eosin (HE) staining on the copper distribution and concentration in liver needle biopsy samples originating from patients with Wilson's disease (WD), a rare autosomal recessive inherited disorder of the copper metabolism, is investigated.
Wei-Ting Chen et al.
Cell, 182(4), 976-991 (2020-07-24)
Although complex inflammatory-like alterations are observed around the amyloid plaques of Alzheimer's disease (AD), little is known about the molecular changes and cellular interactions that characterize this response. We investigate here, in an AD mouse model, the transcriptional changes occurring
Federica Francescangeli et al.
Journal of experimental & clinical cancer research : CR, 39(1), 2-2 (2020-01-09)
Quiescent/slow cycling cells have been identified in several tumors and correlated with therapy resistance. However, the features of chemoresistant populations and the molecular factors linking quiescence to chemoresistance are largely unknown. A population of chemoresistant quiescent/slow cycling cells was isolated
Lucía Barbier-Torres et al.
Nature communications, 11(1), 3360-3360 (2020-07-06)
Nonalcoholic fatty liver disease (NAFLD) is considered the next major health epidemic with an estimated 25% worldwide prevalence. No drugs have yet been approved and NAFLD remains a major unmet need. Here, we identify MCJ (Methylation-Controlled J protein) as a
Marshall W Hogarth et al.
Nature communications, 8, 14143-14143 (2017-02-01)
Duchenne muscular dystrophy (DMD) is characterized by muscle degeneration and progressive weakness. There is considerable inter-patient variability in disease onset and progression, which can confound the results of clinical trials. Here we show that a common null polymorphism (R577X) in
Afficher tous les articles scientifiques apparentés

Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..

Contacter notre Service technique